Stevanato Group S.p.A.(STVN)Earnings, Financials & Key Ratios
STVN•NYSE
$18.34
32.8× P/E·Price updated Jul 7, 2026
AboutStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.Show more
- Revenue$1.14B+3.2%
- EBITDA$268M+10.9%
- Net Income$134M+14.0%
- EPS (Diluted)0.49+14.0%
- Gross Margin28.99%+5.9%
- EBITDA Margin23.54%+7.5%
- Operating Margin16.07%+10.1%
- Net Margin11.78%+10.5%
- ROE9.29%
STVN Price & Volume
Stevanato Group S.p.A. (STVN) stock price & volume — 10-year historical chart
Loading chart...
Capital Intensity Challenges Stevanato's Operating Margin Scalability
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Mixed
Profitability:Moderate
Financial:Healthy
Cash Flow:Mixed
Primary Risk:High capital expenditure intensity
Key Thesis Takeaways
- Stevanato Group is navigating a complex transition as it scales its global manufacturing footprint to meet demand for high-value drug delivery solutions, though this strategy currently pressures free cash flow.
- While the company maintains a conservative debt-to-equity ratio of 0.29, investors should monitor the volatility in operating margins, which have fluctuated between 10.7% and 20.2% over the last ten quarters.
- Future performance remains contingent on the firm's ability to convert its $1.5 billion investment in property, plant, and equipment into consistent, high-margin revenue growth.
Verdict Logic
while the balance sheet remains healthy with a 0.29 debt-to-equity ratio, the inconsistent free cash flow margins and high capital intensity, which saw CapEx/Revenue reach 24.2% in 2026Q1, warrant a cautious wait-and-see approach.
STVN Growth Metrics
Stevanato Group S.p.A. (STVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years11.47%
3 Years5.02%
TTM6.7%
Profit CAGR
10 Years-
5 Years11.33%
3 Years-2.04%
TTM12.33%
EPS CAGR
10 Years-
5 Years11.84%
3 Years-2.58%
TTM9.54%
Return on Capital
10 Years13.7%
5 Years13.93%
3 Years11.34%
Last Year9.49%
STVN Recent Earnings
Stevanato Group S.p.A. (STVN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.13+8.3%
$0.12
Rev
$316M+1.8%
$310M
Q2 2026
Mar 4, 2026Metric
Actual
Est
EPS
$0.21+5.0%
$0.20
Rev
$407M+4.0%
$391M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.16+14.3%
$0.14
Rev
$355M-7.9%
$385M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.12+9.1%
$0.11
Rev
$330M-3.9%
$343M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.13vs $0.12+8.3% | $316Mvs $310M+1.8% |
| Q2 2026 | Mar 4, 2026 | $0.21vs $0.20+5.0% | $407Mvs $391M+4.0% |
| Q4 2025 | Nov 6, 2025 | $0.16vs $0.14+14.3% | $355Mvs $385M-7.9% |
| Q3 2025 | Aug 5, 2025 | $0.12vs $0.11+9.1% | $330Mvs $343M-3.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Stevanato Group S.p.A. (STVN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $18.34 | $5.01B | 32.75 | 3.21% | 11.78% | 9.29% | 0.32% | |
| $38.97 | $813.24M | 15.46 | 3.21% | 4.88% | 13.43% | — | |
| $168.11 | $5.38B | 35.39 | 8.75% | 14.95% | 12.38% | — | |
| $156.30 | $56.63B | 26.81 | 8.23% | 5.33% | 4.54% | — | |
| $356.08 | $25.67B | 52.36 | 6.26% | 16.85% | 17.87% | — | |
| $209.29 | $10.02B | 634.21 | 2.49% | -0.63% | -0.78% | — |
Compare STVN vs Peers
Stevanato Group S.p.A. (STVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when STVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STVN Frequently Asked Questions
Stevanato Group S.p.A. (STVN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Stevanato Group S.p.A.'s revenue?
Stevanato Group S.p.A. (STVN) reported $1.20B in revenue for fiscal year 2025. This represents a 124% increase from $536.5M in 2019.
How fast is Stevanato Group S.p.A. growing?
Stevanato Group S.p.A. (STVN) grew revenue by 3.2% over the past year. Growth has been modest.
Is STVN profitable?
Yes, Stevanato Group S.p.A. (STVN) is profitable, generating $140.9M in net income for fiscal year 2025 (11.8% net margin).
Dividend & Returns
Does STVN pay dividends?
Yes, Stevanato Group S.p.A. (STVN) pays a dividend with a yield of 0.32%. This makes it attractive for income-focused investors.
What is STVN's return on equity?
Stevanato Group S.p.A. (STVN) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.
What is Stevanato Group S.p.A.'s free cash flow?
Stevanato Group S.p.A. (STVN) had negative free cash flow of $7.1M in fiscal year 2025, likely due to heavy capital investments.